These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 3286278

  • 1. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor.
    Monroy RL, Skelly RR, Taylor P, Dubois A, Donahue RE, MacVittie TJ.
    Exp Hematol; 1988 Jun; 16(5):344-8. PubMed ID: 3286278
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of recombinant GM-CSF on the recovery of monkeys transplanted with autologous bone marrow.
    Monroy RL, Skelly RR, MacVittie TJ, Davis TA, Sauber JJ, Clark SC, Donahue RE.
    Blood; 1987 Nov; 70(5):1696-9. PubMed ID: 3311210
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
    Neelis KJ, Dubbelman YD, Qingliang L, Thomas GR, Eaton DL, Wagemaker G.
    Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906
    [Abstract] [Full Text] [Related]

  • 10. Abnormal responses of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor in human cyclic neutropenia.
    Wright DG, LaRussa VF, Salvado AJ, Knight RD.
    J Clin Invest; 1989 Apr; 83(4):1414-8. PubMed ID: 2649515
    [Abstract] [Full Text] [Related]

  • 11. Cell cycle status of erythroid (BFU-E) progenitor cells from the bone marrows of patients on a clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Vadhan-Raj S.
    Exp Hematol; 1989 Jun; 17(5):455-9. PubMed ID: 2653858
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
    Geissler D, Niederwieser D, Aulitzky WE, Tilg H, Grünewald K, Huber C, Konwalinka G.
    Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 17. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.
    Farese AM, Hunt P, Grab LB, MacVittie TJ.
    J Clin Invest; 1996 May 01; 97(9):2145-51. PubMed ID: 8621805
    [Abstract] [Full Text] [Related]

  • 18. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
    Tomer A, Stahl CP, McClure HM, Anderson DC, Myers LA, Liehl E, Winton EF.
    Exp Hematol; 1993 Nov 01; 21(12):1577-82. PubMed ID: 8405239
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
    Bone Marrow Transplant; 1998 Oct 01; 22(7):625-30. PubMed ID: 9818688
    [Abstract] [Full Text] [Related]

  • 20. The clinical use of hematopoietic growth factors.
    Appelbaum FR.
    Semin Hematol; 1989 Jul 01; 26(3 Suppl 3):7-14. PubMed ID: 2477905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.